Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $2.79M fell 68.5% year over year, behind the -21.4% change in trailing-twelve-month research & development. Sequentially, it fell 22.3% from the prior quarter. Over 3 fiscal years it compounded at +21.6% a year.
Context
- Research & development amounted to 117.6% of revenue in FY2025, down 36.7 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -68.5% toward the trailing-twelve-month pace of -21.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 22.8M USD
- Year-over-year change
- +28.1%
- 4-year CAGR
- +2.8%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.8M | +28.1% |
| FY2024 | 2024-12-31 | 17.8M | -24.4% |
| FY2023 | 2023-12-31 | 23.54M | +85.6% |
| FY2022 | 2022-12-31 | 12.68M | -37.8% |
| FY2021 | 2021-12-31 | 20.38M | — |
Research & Development vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's LTM Mar 2026 research & development of $16.75M is the 6th highest of the 10 companies compared; the peer median is $30.07M.
- Its year-over-year change of -21.4% is the 6th highest of 10, against a peer median of -19.9%.
- Research & development amounts to 90.7% of revenue for SLGL, versus a peer median of 5009.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $3.68B | +26273.1% | +50.2% | 46313.4% | |
| LTM Mar 2026 | $135.36M | -19.9% | -12.2% | 86.2% | |
| LTM Mar 2026 | $108.76M | -25.2% | -14.7% | — | |
| LTM Mar 2026 | $79.04M | -54.8% | +4.0% | — | |
| LTM Mar 2026 | $30.07M | -8.9% | +1.3% | 422.2% | |
| LTM Mar 2026 | $16.75M | -21.4% | +21.6% | 90.7% | |
| LTM Mar 2026 | $12.86M | -17.9% | -24.0% | 9596.3% | |
| FY2025 | $10.28M | +96.6% | -13.6% | — | |
| LTM Mar 2026 | $5.77M | -21.5% | -38.7% | — | |
| FY2025 | $2.25M | -72.7% | +11.9% | — | |
| Peer median (excluding SLGL) | $30.07M | -19.9% | -12.2% | 5009.2% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 31.27M | 3.88M | 1.55M | 11.54M | 19.39M |
| Cost of Revenue | 20.38M | 12.68M | 342K | 233K | 109K |
| Gross Profit | 10.89M | (8.8M) | (21.99M) | 11.31M | 19.39M |
| Gross Margin | 34.8% | -226.6% | -1414.9% | 98.0% | 100.0% |
| Research & Development | 20.38M | 12.68M | 23.54M | 17.8M | 22.8M |
| Selling, General & Admin | 8.45M | 7.45M | 7.37M | 5.75M | 4.18M |
| Operating Expenses | 7.93M | 7.45M | 7.32M | 23.32M | 26.93M |
| Depreciation & Amortization | 880K | 562K | 342K | 233K | 109K |
| EBITDA | 3.84M | (15.68M) | (28.96M) | (10.35M) | (7.43M) |
| EBITDA Margin | 12.3% | -403.9% | -1863.8% | -89.7% | -38.3% |
| Operating Income | 2.96M | (16.24M) | (29.31M) | (12.01M) | (7.54M) |
| Operating Margin | 9.5% | -418.3% | -1885.8% | -104.1% | -38.9% |
| Interest Income | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 257K | 1.32M | 2.07M | 1.43M | 1.41M |
| Income Before Tax | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Pre-Tax Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 3.22M | (14.92M) | (27.24M) | (10.58M) | (6.13M) |
| Net Margin | 10.3% | -384.3% | -1752.8% | -91.7% | -31.6% |
| EPS (Basic) | 1.40 | (0.65) | (1.01) | (0.38) | (2.20) |
| EPS (Diluted) | 0.14 | (0.65) | (1.01) | (0.38) | (2.20) |
| Weighted Avg Shares | 23.06M | 23.13M | 27.09M | 27.86M | 2.79M |
| Weighted Avg Shares (Diluted) | 23.57M | 23.13M | 27.09M | 27.86M | 2.79M |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.